Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge Advises EQT on Transfer of the Finnish Finn-Power Group
Mandate

Vinge Advises EQT on Transfer of the Finnish Finn-Power Group

February 27, 2008

Vinge advises EQT on transfer of the Finnish Finn-Power Group to Prima Industries, listed in Italy. By the acquisition of the Finn-Power Group Prima Industries will reach 50 countries which in turn will make Prima Industries the third largest producer of laser machines in the world. The group’s annual revenues are calculated to reach an estimated value of EUR 400 million.      

EQT is represented by partner Anders Åberg joined by associates Tuula Tallavarra and Petter Kjöllerström assisted by project assistant Jenny Henriksson.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026